Skip to main content
. 2009 May;4(5):957–964. doi: 10.2215/CJN.00010109

Table 1.

Characteristics of all Australian PD patients who did and did not experience Pseudomonas peritonitis at any stage during the period 2003 through 2006a

Characteristic Pseudomonas Peritonitis (n = 171) No Pseudomonas Peritonitis (n = 4504) P
Age (yr; mean ± SD) 59.3 ± 19.3 61.6 ± 16.6 0.080
Women (n [%]) 73 (43) 2053 (46) 0.500
Racial origin (n [%]) 0.001
    white 122 (71) 3459 (77)
    Aboriginal/Torres Strait Islander 23 (13) 365 (8)
    Maori/Pacific Islander 8 (5) 73 (2)
    Asian 12 (7) 429 (10)
    other 6 (4) 178 (4)
BMI (kg/m2; mean ± SD) 25.9 ± 6.4 25.4 ± 5.7 0.400
eGFR at dialysis start (ml/min per 1.73 m2; mean ± SD) 7.1 ± 5.0 7.3 ± 10.5 0.800
Late referral (n [%]) 46 (27) 1065 (24) 0.300
ESRF cause (n [%]) 0.200
    chronic glomerulonephritis 50 (29) 1273 (28)
    diabetic nephropathy 41 (24) 1278 (28)
    renovascular disease 18 (11) 621 (14)
    polycystic kidneys 7 (4) 189 (4)
    reflux nephropathy 8 (5) 189 (4)
    other 29 (17) 616 (14)
    unknown 18 (11) 278 (6)
Current smoker (n [%]) 18 (11) 539 (12) 0.200
Chronic lung disease (n [%]) 22 (13) 577 (13) 1.000
Coronary artery disease (n [%]) 58 (34) 1609 (36) 0.600
Peripheral vascular disease (n [%]) 28 (16) 1018 (23) 0.800
Cerebrovascular disease (n [%]) 25 (15) 583 (13) 0.500
Diabetes (n [%]) 57 (33) 1681 (37) 0.300
Peritoneal transport status (n [%]) 0.800
    high 14 (8) 457 (10)
    high average 64 (37) 1647 (37)
    low average 37 (22) 1041 (23)
    low 9 (5) 189 (4)
    unknown/not specified 47 (27) 1170 (26)
Centre size (no. of PD patients; n [%]) 0.600
    small (≤10) 2 (1) 53 (1)
    small-medium (11 to 38) 15 (9) 306 (7)
    medium-large (39 to 98) 32 (19) 996 (22)
    large (≥99) 122 (71) 3149 (70)
State <0.001
    New South Wales 77 (45) 1755 (39)
    Northern Territory 8 (5) 77 (2)
    Queensland 37 (22) 918 (20)
    South Australia 13 (8) 282 (6)
    Tasmania 1 (1) 76 (2)
    Victoria 14 (8) 946 (21)
    Western Australia 21 (12) 450 (10)
a

BMI, body mass index; eGFR, estimated GFR; ESRF, end-stage renal failure; PD, peritoneal dialysis.